A patient under study by Kala 2022 showed mutated MAP2K1 and Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2) genes, suggesting MAPK/ERK pathway mutations as the most common alterations in RDD [38]. This evidence concerns the gene MAPK1 and sinus histiocytosis with massive lymphadenopathy.